Mediclinic International PLC (LON:MDC) has been given an average recommendation of “Hold” by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and six have given a hold rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is GBX 725.71 ($9.64).
Several research analysts recently weighed in on MDC shares. Investec lowered shares of Mediclinic International PLC to a “hold” rating and set a GBX 775 ($10.30) target price for the company. in a report on Monday, June 26th. Citigroup Inc. reaffirmed a “neutral” rating and set a GBX 790 ($10.50) target price on shares of Mediclinic International PLC in a report on Tuesday, June 27th. Morgan Stanley lowered shares of Mediclinic International PLC to an “equal weight” rating and lowered their target price for the stock from GBX 825 ($10.96) to GBX 775 ($10.30) in a report on Thursday, June 29th. Credit Suisse Group reaffirmed a “neutral” rating on shares of Mediclinic International PLC in a report on Friday, July 21st. Finally, Jefferies Group LLC lowered their target price on shares of Mediclinic International PLC from GBX 650 ($8.64) to GBX 550 ($7.31) and set an “underperform” rating for the company in a report on Monday, September 25th.
Mediclinic International PLC (LON:MDC) traded down 0.93% during midday trading on Wednesday, hitting GBX 639.50. The stock had a trading volume of 3,378,167 shares. Mediclinic International PLC has a one year low of GBX 630.00 and a one year high of GBX 941.50. The stock’s 50-day moving average is GBX 695.84 and its 200-day moving average is GBX 748.22. The company’s market cap is GBX 4.71 billion.
TRADEMARK VIOLATION WARNING: This piece was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.com-unik.info/2017/10/18/mediclinic-international-plc-mdc-receives-average-rating-of-hold-from-analysts.html.
About Mediclinic International PLC
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
What are top analysts saying about Mediclinic International PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mediclinic International PLC and related companies.